Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201109111 Principal Investigator: Van Tine, Brian
Title: A Randomized Phase 3, Multicenter, Open-Label Study Comparing TH-302 in Combination with Doxorubicin vs. Doxorubicin Alone in Subjects with Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma
Phase: III Disease Site: Soft Tissue
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this research study is to find out if an investigational drug called TH-302 can help patients with advanced soft tissue sarcoma when it is combined with doxorubicin. The purpose of this study is to gather information on the safety and effect on cancer of TH-302 in combination with doxorubicin.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)